CD52(Antibody) Market - Global Outlook and Forecast 2022-2028

January 2022 | 66 pages | ID: C40CB2F4150DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of CD52(Antibody) in Global, including the following market information:

Global CD52(Antibody) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CD52(Antibody) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CD52(Antibody) include Thermo Fisher Scientific, R&D Systems, Bio-Rad, Lifespan Biosciences, Abbexa Ltd, Boster Bio, Aviva Systems Biology, Biobyt and Genetex and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD52(Antibody) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CD52(Antibody) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CD52(Antibody) Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global CD52(Antibody) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CD52(Antibody) Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global CD52(Antibody) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CD52(Antibody) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CD52(Antibody) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CD52(Antibody) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Bio-Rad
• Lifespan Biosciences
• Abbexa Ltd
• Boster Bio
• Aviva Systems Biology
• Biobyt
• Genetex
• ProteoGenix

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CD52(Antibody) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CD52(Antibody) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CD52(ANTIBODY) OVERALL MARKET SIZE

2.1 Global CD52(Antibody) Market Size: 2021 VS 2028
2.2 Global CD52(Antibody) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CD52(Antibody) Players in Global Market
3.2 Top Global CD52(Antibody) Companies Ranked by Revenue
3.3 Global CD52(Antibody) Revenue by Companies
3.4 Top 3 and Top 5 CD52(Antibody) Companies in Global Market, by Revenue in 2021
3.5 Global Companies CD52(Antibody) Product Type
3.6 Tier 1, Tier 2 and Tier 3 CD52(Antibody) Players in Global Market
  3.6.1 List of Global Tier 1 CD52(Antibody) Companies
  3.6.2 List of Global Tier 2 and Tier 3 CD52(Antibody) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global CD52(Antibody) Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global CD52(Antibody) Revenue & Forecasts
  4.2.1 By Type - Global CD52(Antibody) Revenue, 2017-2022
  4.2.2 By Type - Global CD52(Antibody) Revenue, 2023-2028
  4.2.3 By Type - Global CD52(Antibody) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CD52(Antibody) Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global CD52(Antibody) Revenue & Forecasts
  5.2.1 By Application - Global CD52(Antibody) Revenue, 2017-2022
  5.2.2 By Application - Global CD52(Antibody) Revenue, 2023-2028
  5.2.3 By Application - Global CD52(Antibody) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CD52(Antibody) Market Size, 2021 & 2028
6.2 By Region - Global CD52(Antibody) Revenue & Forecasts
  6.2.1 By Region - Global CD52(Antibody) Revenue, 2017-2022
  6.2.2 By Region - Global CD52(Antibody) Revenue, 2023-2028
  6.2.3 By Region - Global CD52(Antibody) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America CD52(Antibody) Revenue, 2017-2028
  6.3.2 US CD52(Antibody) Market Size, 2017-2028
  6.3.3 Canada CD52(Antibody) Market Size, 2017-2028
  6.3.4 Mexico CD52(Antibody) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe CD52(Antibody) Revenue, 2017-2028
  6.4.2 Germany CD52(Antibody) Market Size, 2017-2028
  6.4.3 France CD52(Antibody) Market Size, 2017-2028
  6.4.4 U.K. CD52(Antibody) Market Size, 2017-2028
  6.4.5 Italy CD52(Antibody) Market Size, 2017-2028
  6.4.6 Russia CD52(Antibody) Market Size, 2017-2028
  6.4.7 Nordic Countries CD52(Antibody) Market Size, 2017-2028
  6.4.8 Benelux CD52(Antibody) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia CD52(Antibody) Revenue, 2017-2028
  6.5.2 China CD52(Antibody) Market Size, 2017-2028
  6.5.3 Japan CD52(Antibody) Market Size, 2017-2028
  6.5.4 South Korea CD52(Antibody) Market Size, 2017-2028
  6.5.5 Southeast Asia CD52(Antibody) Market Size, 2017-2028
  6.5.6 India CD52(Antibody) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America CD52(Antibody) Revenue, 2017-2028
  6.6.2 Brazil CD52(Antibody) Market Size, 2017-2028
  6.6.3 Argentina CD52(Antibody) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CD52(Antibody) Revenue, 2017-2028
  6.7.2 Turkey CD52(Antibody) Market Size, 2017-2028
  6.7.3 Israel CD52(Antibody) Market Size, 2017-2028
  6.7.4 Saudi Arabia CD52(Antibody) Market Size, 2017-2028
  6.7.5 UAE CD52(Antibody) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific CD52(Antibody) Major Product Offerings
  7.1.4 Thermo Fisher Scientific CD52(Antibody) Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems CD52(Antibody) Major Product Offerings
  7.2.4 R&D Systems CD52(Antibody) Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Bio-Rad
  7.3.1 Bio-Rad Corporate Summary
  7.3.2 Bio-Rad Business Overview
  7.3.3 Bio-Rad CD52(Antibody) Major Product Offerings
  7.3.4 Bio-Rad CD52(Antibody) Revenue in Global Market (2017-2022)
  7.3.5 Bio-Rad Key News
7.4 Lifespan Biosciences
  7.4.1 Lifespan Biosciences Corporate Summary
  7.4.2 Lifespan Biosciences Business Overview
  7.4.3 Lifespan Biosciences CD52(Antibody) Major Product Offerings
  7.4.4 Lifespan Biosciences CD52(Antibody) Revenue in Global Market (2017-2022)
  7.4.5 Lifespan Biosciences Key News
7.5 Abbexa Ltd
  7.5.1 Abbexa Ltd Corporate Summary
  7.5.2 Abbexa Ltd Business Overview
  7.5.3 Abbexa Ltd CD52(Antibody) Major Product Offerings
  7.5.4 Abbexa Ltd CD52(Antibody) Revenue in Global Market (2017-2022)
  7.5.5 Abbexa Ltd Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio CD52(Antibody) Major Product Offerings
  7.6.4 Boster Bio CD52(Antibody) Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Aviva Systems Biology
  7.7.1 Aviva Systems Biology Corporate Summary
  7.7.2 Aviva Systems Biology Business Overview
  7.7.3 Aviva Systems Biology CD52(Antibody) Major Product Offerings
  7.7.4 Aviva Systems Biology CD52(Antibody) Revenue in Global Market (2017-2022)
  7.7.5 Aviva Systems Biology Key News
7.8 Biobyt
  7.8.1 Biobyt Corporate Summary
  7.8.2 Biobyt Business Overview
  7.8.3 Biobyt CD52(Antibody) Major Product Offerings
  7.8.4 Biobyt CD52(Antibody) Revenue in Global Market (2017-2022)
  7.8.5 Biobyt Key News
7.9 Genetex
  7.9.1 Genetex Corporate Summary
  7.9.2 Genetex Business Overview
  7.9.3 Genetex CD52(Antibody) Major Product Offerings
  7.9.4 Genetex CD52(Antibody) Revenue in Global Market (2017-2022)
  7.9.5 Genetex Key News
7.10 ProteoGenix
  7.10.1 ProteoGenix Corporate Summary
  7.10.2 ProteoGenix Business Overview
  7.10.3 ProteoGenix CD52(Antibody) Major Product Offerings
  7.10.4 ProteoGenix CD52(Antibody) Revenue in Global Market (2017-2022)
  7.10.5 ProteoGenix Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. CD52(Antibody) Market Opportunities & Trends in Global Market
Table 2. CD52(Antibody) Market Drivers in Global Market
Table 3. CD52(Antibody) Market Restraints in Global Market
Table 4. Key Players of CD52(Antibody) in Global Market
Table 5. Top CD52(Antibody) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CD52(Antibody) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CD52(Antibody) Revenue Share by Companies, 2017-2022
Table 8. Global Companies CD52(Antibody) Product Type
Table 9. List of Global Tier 1 CD52(Antibody) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD52(Antibody) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CD52(Antibody) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CD52(Antibody) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CD52(Antibody) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CD52(Antibody) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CD52(Antibody) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CD52(Antibody) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CD52(Antibody) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CD52(Antibody) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CD52(Antibody) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CD52(Antibody) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CD52(Antibody) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CD52(Antibody) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CD52(Antibody) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CD52(Antibody) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CD52(Antibody) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CD52(Antibody) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CD52(Antibody) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CD52(Antibody) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CD52(Antibody) Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific CD52(Antibody) Product Offerings
Table 32. Thermo Fisher Scientific CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems CD52(Antibody) Product Offerings
Table 35. R&D Systems CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Corporate Summary
Table 37. Bio-Rad CD52(Antibody) Product Offerings
Table 38. Bio-Rad CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 39. Lifespan Biosciences Corporate Summary
Table 40. Lifespan Biosciences CD52(Antibody) Product Offerings
Table 41. Lifespan Biosciences CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 42. Abbexa Ltd Corporate Summary
Table 43. Abbexa Ltd CD52(Antibody) Product Offerings
Table 44. Abbexa Ltd CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio CD52(Antibody) Product Offerings
Table 47. Boster Bio CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 48. Aviva Systems Biology Corporate Summary
Table 49. Aviva Systems Biology CD52(Antibody) Product Offerings
Table 50. Aviva Systems Biology CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 51. Biobyt Corporate Summary
Table 52. Biobyt CD52(Antibody) Product Offerings
Table 53. Biobyt CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 54. Genetex Corporate Summary
Table 55. Genetex CD52(Antibody) Product Offerings
Table 56. Genetex CD52(Antibody) Revenue (US$, Mn), (2017-2022)
Table 57. ProteoGenix Corporate Summary
Table 58. ProteoGenix CD52(Antibody) Product Offerings
Table 59. ProteoGenix CD52(Antibody) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. CD52(Antibody) Segment by Type in 2021
Figure 2. CD52(Antibody) Segment by Application in 2021
Figure 3. Global CD52(Antibody) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CD52(Antibody) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CD52(Antibody) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CD52(Antibody) Revenue in 2021
Figure 8. By Type - Global CD52(Antibody) Revenue Market Share, 2017-2028
Figure 9. By Application - Global CD52(Antibody) Revenue Market Share, 2017-2028
Figure 10. By Region - Global CD52(Antibody) Revenue Market Share, 2017-2028
Figure 11. By Country - North America CD52(Antibody) Revenue Market Share, 2017-2028
Figure 12. US CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CD52(Antibody) Revenue Market Share, 2017-2028
Figure 16. Germany CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 17. France CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CD52(Antibody) Revenue Market Share, 2017-2028
Figure 24. China CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 28. India CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CD52(Antibody) Revenue Market Share, 2017-2028
Figure 30. Brazil CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CD52(Antibody) Revenue Market Share, 2017-2028
Figure 33. Turkey CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CD52(Antibody) Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Lifespan Biosciences CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbexa Ltd CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aviva Systems Biology CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biobyt CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Genetex CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ProteoGenix CD52(Antibody) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)